The Future of Psychedelics: A Discussion with Rick Doblin & Steven LevineThe Future of Psychedelics: A Discussion with Rick Doblin & Steven Levine
Shrink Speak
In this episode, Dr. Jeffrey Lieberman is joined by pioneering psychedelics researchers, Drs. Rick Doblin and Steven Levine, to discuss the therapeutic applications of psychedelic drugs such as psilocybin, ketamine, LSD, MDMA, and ibogaine in treatin...
1:04:08•29 Sept 2021
Psychedelics in Therapy: Insights from Rick Doblin & Steven Levine
“Psychedelics are not for people that don't want to take them.”
Imagine a world where psychedelics are a cornerstone of mental health treatment. In this thought-provoking episode of 'Shrink Speak', Dr. Jeffrey Lieberman sits down with two trailblazers in the field, Dr. Rick Doblin and Dr. Steven Levine, to discuss just that. Dr. Doblin, the founder of MAPS, and Dr.
Levine, a pioneer in ketamine therapy, bring their extensive experience to the table, exploring how substances like psilocybin, ketamine, LSD, MDMA, and ibogaine could revolutionize the treatment of mental health and addiction disorders. They don't shy away from the tough questions either—delving into the challenges of psychedelic research, the spiritual aspects of these substances, and the evolving landscape of drug policy.
Whether you're curious about the science behind these treatments or interested in their broader societal implications, this episode offers a fascinating glimpse into the future of mental health care.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.